State Street Corp Bellerophon Therapeutics, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.9 - $7.89 $7,920 - $69,432	8,800 Added 41.26%	30,127 $237,000
Q3 2021 Nov 15, 2021	BUY	$3.75 - $4.86 $1,125 - $1,458	300 Added 1.43%	21,327 $87,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $5.65 $137,761 - $203,224	-35,969 Reduced 63.11%	21,027 $102,000
Q1 2021 May 17, 2021	SELL	$5.07 - $8.27 $114,485 - $186,744	-22,581 Reduced 28.38%	56,996 $296,000
Q4 2020 Feb 16, 2021	BUY	$6.12 - $10.37 $125,460 - $212,584	20,500 Added 34.7%	79,577 $531,000
Q3 2020 Nov 10, 2020	BUY	$9.27 - $13.79 $248,204 - $369,227	26,775 Added 82.89%	59,077 $601,000
Q2 2020 Aug 14, 2020	BUY	$9.43 - $20.28 $304,607 - $655,084	32,302 New	32,302 $405,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $573K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.